Transplantation of bone marrow and peripheral stem cells

被引:2
作者
Alvegard, T
机构
[1] CTR ONCOL, LUND, SWEDEN
[2] CANC SOC, STOCKHOLM, SWEDEN
[3] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.3109/02841869609101674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This synthesis of the literature on radiotherapy related to bone marrow transplantation is based on 59 scientific articles, including 5 randomized studies and 20 retrospective studies. These studies involve 2563 patients. Bone marrow transplantation is a rapidly expanding treatment method where whole-body irradiation can play an important role. The literature review reveals that treatment methods for whole-body irradiation are highly heterogeneous. Standardization would be desirable. Fractionated and single-dose, whole-body irradiation are probably of equal value when the dose and technique are optimal. Cataracts seem to be more common following a single dose. Fractionated treatment is more resource intensive, but less burdensome for patients. For advanced-stage leukemia and some other diseases, eg, myeloma, international experience has shown that a combined treatment strategy (high-dose cyclophosphamide and whole-body irradiation) is probably superior to chemotherapy (cyclophosphamide and busulfan) alone. For many other hematological malignancies at less advanced stages, conditioning methods are probably of equal value.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 58 条
[1]   TREATMENT OF MALIGNANT-LYMPHOMA IN 100 PATIENTS WITH CHEMOTHERAPY, TOTAL-BODY IRRADIATION, AND MARROW TRANSPLANTATION [J].
APPELBAUM, FR ;
SULLIVAN, KM ;
BUCKNER, CD ;
CLIFT, RA ;
DEEG, HJ ;
FEFER, A ;
HILL, R ;
MORTIMER, J ;
NEIMAN, PE ;
SANDERS, JE ;
SINGER, J ;
STEWART, P ;
STORB, R ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1340-1347
[2]  
ARMITAGE JO, 1986, CANCER TREAT REP, V70, P871
[3]   INTERSTITIAL PNEUMONITIS FOLLOWING BONE-MARROW TRANSPLANTATION AFTER LOW-DOSE RATE TOTAL-BODY IRRADIATION [J].
BARRETT, A ;
DEPLEDGE, MH ;
POWLES, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (07) :1029-1033
[4]  
BLAISE D, 1992, BLOOD, V79, P2578
[5]   GROWTH IN CHILDREN AFTER BONE-MARROW TRANSPLANTATION [J].
BOZZOLA, M ;
GIORGIANI, G ;
LOCATELLI, F ;
CISTERNINO, M ;
GAMBARANA, D ;
ZECCA, M ;
TORCETTA, F ;
SEVERI, F .
HORMONE RESEARCH, 1993, 39 (3-4) :122-126
[6]  
Briot E, 1990, Radiother Oncol, V18 Suppl 1, P16, DOI 10.1016/0167-8140(90)90175-V
[7]   AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - AN UPDATE OF THE GENOA EXPERIENCE WITH 159 PATIENTS [J].
CARELLA, AM ;
FRASSONI, F ;
VANLINT, MT ;
GUALANDI, F ;
OCCHINI, D ;
CARLIER, P ;
POLLICARDO, N ;
PUNGOLINO, E ;
FAGIOLI, F ;
SANTINI, G ;
CONGIU, A ;
NATI, S ;
RAFFO, MR ;
PODESTA, M ;
CORVO, R ;
VITALE, V ;
GALLAMINI, A ;
POGLIANI, EM ;
LANZI, E ;
BACIGALUPO, A ;
MARMONT, AM .
ANNALS OF HEMATOLOGY, 1992, 64 (03) :128-131
[8]  
CHAMPLIN R, 1987, SEMIN HEMATOL, V24, P55
[9]  
CHAMPLIN R, 1993, BLOOD, V81, P277
[10]  
CHAMPLIN RE, 1987, TRANSPLANT P, V19, P2616